Cheryl Meguid, DNP, NP

Professional Titles

• Pancreas & Biliary Cancer Multidisciplinary Clinic Coordinator
• Regional Medical Director, Oncology Multidisciplinary Programs
• Associate Vice Chair of Faculty Affairs for APPs, Department of Surgery
• Director, Pancreatic Cancer High Risk Screening Clinic
• Professor of Clinical Practice, Department of Surgery

Recognitions

• Full-Time Allied/Associate Staff Clinician of the Year, University of Colorado Hospital Medical Staff Office (2016)

Publications

• Yee EJ, Torphy RJ, Myers EK, Meguid C, Franklin O, Sugawara T, Franco SR, Clark TJ, Mungo B, Ahrendt SA, Schulick RD, Del Chiaro M, McCarter MM. Dynamic Anthropometrics in Pancreatic Cancer: Associations Between Body Composition Changes During Neoadjuvant Therapy and Survival Outcomes After Resection. Ann Surg Oncol. 2024 Nov;31(12):8340-8351. PubMed PMID: 39120842
• McCranie A, Lee AD, Leonard L, Vemuru S, Huynh V, D'Angelo J, D'Angelo AL, Ahrendt G, Kaoutzanis C, Fisher C, Gleisner A, Meguid C, Schulick R, Del Chiaro M, Tevis S. Exploration of Patient Retention in Seeking a Second Opinion: A Retrospective Cohort Study. J Surg Res. 2024 May 28. [Epub ahead of print] PubMed PMID: 38811259
• Stuart CM, Kirsch MJ, Zhuang Y, Meguid CL, Sugawara T, Colborn KL, Messersmith W, Lieu C, Gleisner AL, Del Chiaro M, Schulick RD, Meguid RA. Pulmonary metastasectomy is associated with survival after lung-only recurrence in pancreatic cancer. Surgery. 2023 Sep;174(3):654-659. PubMed PMID: 37391327
• Duarte C, Hu J, Beuselinck B, Panian J, Weise N, Dizman N, Collier KA, Rathi N, Li H, Elias R, Martinez-Chanza N, Rose TL, Harshman LC, Gopalakrishnan D, Vaishampayan U, Zakharia Y, Narayan V, Carneiro BA, Mega A, Singla N, Meguid C, George S, Brugarolas J, Agarwal N, Mortazavi A, Pal S, McKay RR, Lam ET. Metastatic renal cell carcinoma to the pancreas and other sites-a multicenter retrospective study. EClinicalMedicine. 2023 Jun;60:102018. PubMed PMID: 37304495
• Ziogas IA, Rodriguez Franco S, Schmoke N, Meguid C, Murphy C, Al-Musawi M, Alexopoulos SP, Schulick RD, Del Chiaro M. Comparison of Invasive Pancreatic Ductal Adenocarcinoma versus Intraductal Papillary Mucinous Neoplasm: A National Cancer Database Analysis. Cancers (Basel). 2023 Feb 13;15(4). PubMed PMID: 36831527
• Stuart CM, Kirsch MJ, Zhuang Y, Meguid CL, Sugawara T, Colborn KL, Messersmith W, Lieu C, Gleisner AL, Del Chiaro M, Schulick RD, Meguid RA. Pulmonary metastasectomy is associated with survival after lung-only recurrence in pancreatic cancer. Surgery. 2023 Sep;174(3):654-659. PubMed PMID: 37391327
• Duarte C, Hu J, Beuselinck B, Panian J, Weise N, Dizman N, Collier KA, Rathi N, Li H, Elias R, Martinez-Chanza N, Rose TL, Harshman LC, Gopalakrishnan D, Vaishampayan U, Zakharia Y, Narayan V, Carneiro BA, Mega A, Singla N, Meguid C, George S, Brugarolas J, Agarwal N, Mortazavi A, Pal S, McKay RR, Lam ET. Metastatic renal cell carcinoma to the pancreas and other sites-a multicenter retrospective study. EClinicalMedicine. 2023 Jun;60:102018. PubMed PMID: 37304495
• Ziogas IA, Rodriguez Franco S, Schmoke N, Meguid C, Murphy C, Al-Musawi M, Alexopoulos SP, Schulick RD, Del Chiaro M. Comparison of Invasive Pancreatic Ductal Adenocarcinoma versus Intraductal Papillary Mucinous Neoplasm: A National Cancer Database Analysis. Cancers (Basel). 2023 Feb 13;15(4). PubMed PMID: 36831527
• Oba A, Wu YHA, Colborn KL, Karam SD, Meguid C, Al-Musawi MH, Bao QR, Gleisner AL, Ahrendt S, Schulick RD, Del Chiaro M. Comparing neoadjuvant chemotherapy with or without radiation therapy for pancreatic ductal adenocarcinoma: National Cancer Database cohort analysis. Br J Surg. 2022 Apr 19;109(5):450-454. PubMed PMID: 35136963
• Oba A, Croce C, Hosokawa P, Meguid C, Torphy RJ, Al-Musawi MH, Ahrendt S, Gleisner A, Schulick RD, Del Chiaro M. Prognosis Based Definition of Resectability in Pancreatic Cancer: A Road Map to New Guidelines. Ann Surg. 2022 Jan 1;275(1):175-181. PubMed PMID: 32149822
• Oba A, Wu YHA, Colborn KL, Karam SD, Meguid C, Al-Musawi MH, Bao QR, Gleisner AL, Ahrendt S, Schulick RD, Del Chiaro M. Comparing neoadjuvant chemotherapy with or without radiation therapy for pancreatic ductal adenocarcinoma: National Cancer Database cohort analysis. Br J Surg. 2022 Apr 19;109(5):450-454. PubMed PMID: 35136963
• Oba A, Croce C, Hosokawa P, Meguid C, Torphy RJ, Al-Musawi MH, Ahrendt S, Gleisner A, Schulick RD, Del Chiaro M. Prognosis Based Definition of Resectability in Pancreatic Cancer: A Road Map to New Guidelines. Ann Surg. 2022 Jan 1;275(1):175-181. PubMed PMID: 32149822
• Oase, K., Meguid, C., Oba, A., Al-Musawi, M., Sheridan, AD., Norris, E., Mehrotra, S., Lovell, M., Schulick, RD., Ahrendt, SA. & Del Chiaro, M. (2022). Solid Pseudopapillary neoplasm: a single institutional case series of a rare pancreatic tumor. Journal of Advanced Practitioners in Oncology.
• Wu YHA, Oba A, Lin R, Watanabe S, Meguid C, Schulick RD, Del Chiaro M. Selecting surgical candidates with locally advanced pancreatic cancer: a review for modern pancreatology. J Gastrointest Oncol. 2021 Oct;12(5):2475-2483. PubMed PMID: 34790408
• Wu YHA, Oba A, Beaty L, Colborn KL, Rodriguez Franco S, Harnke B, Meguid C, Negrini D, Valente R, Ahrendt S, Schulick RD, Del Chiaro M. Ductal Dilatation of =5 mm in Intraductal Papillary Mucinous Neoplasm Should Trigger the Consideration for Pancreatectomy: A Meta-Analysis and Systematic Review of Resected Cases. Cancers (Basel). 2021 Apr 22;13(9). PubMed PMID: 33922344
• Mueller AC, Piper M, Goodspeed A, Bhuvane S, Williams JS, Bhatia S, Phan AV, Van Court B, Zolman KL, Peña B, Oweida AJ, Zakem S, Meguid C, Knitz MW, Darragh L, Bickett TE, Gadwa J, Mestroni L, Taylor MRG, Jordan KR, Dempsey P, Lucia MS, McCarter MD, Del Chiaro M, Messersmith WA, Schulick RD, Goodman KA, Gough MJ, Greene CS, Costello JC, Neto AG, Lagares D, Hansen KC, Van Bokhoven A, Karam SD. Induction of ADAM10 by Radiation Therapy Drives Fibrosis, Resistance, and Epithelial-to-Mesenchyal Transition in Pancreatic Cancer. Cancer Res. 2021 Jun 15;81(12):3255-3269. PubMed PMID: 33526513
• Zakem SJ, Mueller AC, Meguid C, Torphy RJ, Holt DE, Schefter T, Messersmith WA, McCarter MD, Del Chiaro M, Schulick RD, Goodman KA. Impact of neoadjuvant chemotherapy and stereotactic body radiation therapy (SBRT) on R0 resection rate for borderline resectable and locally advanced pancreatic cancer. HPB (Oxford). 2021 Jul;23(7):1072-1083. PubMed PMID: 33277184
• Wu YHA, Oba A, Lin R, Watanabe S, Meguid C, Schulick RD, Del Chiaro M. Selecting surgical candidates with locally advanced pancreatic cancer: a review for modern pancreatology. J Gastrointest Oncol. 2021 Oct;12(5):2475-2483. PubMed PMID: 34790408
• Wu YHA, Oba A, Beaty L, Colborn KL, Rodriguez Franco S, Harnke B, Meguid C, Negrini D, Valente R, Ahrendt S, Schulick RD, Del Chiaro M. Ductal Dilatation of =5 mm in Intraductal Papillary Mucinous Neoplasm Should Trigger the Consideration for Pancreatectomy: A Meta-Analysis and Systematic Review of Resected Cases. Cancers (Basel). 2021 Apr 22;13(9). PubMed PMID: 33922344
• Mueller AC, Piper M, Goodspeed A, Bhuvane S, Williams JS, Bhatia S, Phan AV, Van Court B, Zolman KL, Peña B, Oweida AJ, Zakem S, Meguid C, Knitz MW, Darragh L, Bickett TE, Gadwa J, Mestroni L, Taylor MRG, Jordan KR, Dempsey P, Lucia MS, McCarter MD, Chiaro MD, Messersmith WA, Schulick RD, Goodman KA, Gough MJ, Greene CS, Costello JC, Neto AG, Lagares D, Hansen KC, Van Bokhoven A, Karam SD. Induction of ADAM10 by Radiation Therapy Drives Fibrosis, Resistance, and Epithelial-to-Mesenchyal Transition in Pancreatic Cancer. Cancer Res. 2021 Jun 15;81(12):3255-3269. PubMed PMID: 33526513
• Zakem SJ, Mueller AC, Meguid C, Torphy RJ, Holt DE, Schefter T, Messersmith WA, McCarter MD, Del Chiaro M, Schulick RD, Goodman KA. Impact of neoadjuvant chemotherapy and stereotactic body radiation therapy (SBRT) on R0 resection rate for borderline resectable and locally advanced pancreatic cancer. HPB (Oxford). 2021 Jul;23(7):1072-1083. PubMed PMID: 33277184
• Wu YHA, Samuels JM, Harnke B, Negrini D, Al-Musawi MH, Meguid C, Ahrendt S, Schulick RD, Del Chiaro M, Oba A. Multifocal/diffuse pancreatic serous cystic neoplasms: Systematic review with a new case. Pancreatology. 2020 Jul;20(5):902-909. PubMed PMID: 32418758
• Oba A, Croce C, Hosokawa P, Meguid C, Torphy RJ, Al-Musawi MH, Ahrendt S, Gleisner A, Schulick RD, Del Chiaro M. Prognosis Based Definition of Resectability in Pancreatic Cancer: A Road Map to New Guidelines. Ann Surg. 2020 Mar 6. [Epub ahead of print] PubMed PMID: 32149822
• Wu YHA, Samuels JM, Harnke B, Negrini D, Al-Musawi MH, Meguid C, Ahrendt S, Schulick RD, Del Chiaro M, Oba A. Multifocal/diffuse pancreatic serous cystic neoplasms: Systematic review with a new case. Pancreatology. 2020 Jul;20(5):902-909. PubMed PMID: 32418758
• Oba A, Croce C, Hosokawa P, Meguid C, Torphy RJ, Al-Musawi MH, Ahrendt S, Gleisner A, Schulick RD, Del Chiaro M. Prognosis Based Definition of Resectability in Pancreatic Cancer: A Road Map to New Guidelines. Ann Surg. 2020 Mar 6. [Epub ahead of print] PubMed PMID: 32149822
• Torphy RJ, Chapman BC, Friedman C, Nguyen C, Bartsch CG, Meguid C, Ahrendt SA, McCarter MD, Del Chiaro M, Schulick RD, Edil BH, Gleisner A. Quality of Life Following Major Laparoscopic or Open Pancreatic Resection. Ann Surg Oncol. 2019 Sep;26(9):2985-2993. PubMed PMID: 31228131
• Torphy RJ, Chapman BC, Friedman C, Nguyen C, Bartsch CG, Meguid C, Ahrendt SA, McCarter MD, Del Chiaro M, Schulick RD, Edil BH, Gleisner A. Quality of Life Following Major Laparoscopic or Open Pancreatic Resection. Ann Surg Oncol. 2019 Sep;26(9):2985-2993. PubMed PMID: 31228131
• Chapman BC, Gleisner A, Rigg D, Messersmith W, Paniccia A, Meguid C, Gajdos C, McCarter MD, Schulick RD, Edil BH. Perioperative and Survival Outcomes Following Neoadjuvant FOLFIRINOX versus Gemcitabine Abraxane in Patients with Pancreatic Adenocarcinoma. JOP. 2018 Mar;19(2):75-85. PubMed PMID: 29950957
• Chapman BC, Gleisner A, Rigg D, Meguid C, Goodman K, Brauer B, Gajdos C, Schulick RD, Edil BH, McCarter MD. Perioperative outcomes and survival following neoadjuvant stereotactic body radiation therapy (SBRT) versus intensity-modulated radiation therapy (IMRT) in pancreatic adenocarcinoma. J Surg Oncol. 2018 Apr;117(5):1073-1083. PubMed PMID: 29448308
• Chapman BC, Gleisner A, Ibrahim-Zada I, Overbey DM, Paniccia A, Meguid C, Brauer B, Gajdos C, McCarter MD, Schulick RD, Edil BH. Laparoscopic pancreaticoduodenectomy: changing the management of ampullary neoplasms. Surg Endosc. 2018 Feb;32(2):915-922. PubMed PMID: 28779245
• Chapman, B., Ibrahim-zada, I., Overbey, D., Paniccia, A., Meguid, C., Brauer, B., Gajdos, C., Gleisner, A., McCarter, M., Schulick, R. & Edil, B. (2017). Laparoscopic Pancreaticoduodenectomy: Changing the Management of Ampullary Neoplasms. Surgical Endoscopy.
• Chapman, B., Gleisner, A., Rigg, D., Messersmith, W., Paniccia, A., Meguid, C., Gajdos, C., McCarter, M. Schulick, R. & Edil, B. Survival Outcomes Following Neoadjuvant FOLFIRINOX vs Gemcitabine/Abraxane in Patients with Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma. Journal of the American College of Surgeons.
• Chapman, B., McCulough, J., Overbey, D., Paniccia, A., Meguid, C., Gleisner, A., McCarter, M., Gajdos C., Schulick, RD., & Edil, BH. (2016). Empiric Post-Operative Metocloperamide Reduces Delayed Gastric Emptying After Pancreaticoduodenectomy. Gastroenterology, 2017.
• Meguid, C. & Schefter, TS. Multidisciplinary Model for Liver Tumors, Chapter 19. Radiation Therapy for Liver Tumors.
• Stewart CL, Meguid C, Chapman B, Schulick R, Edil BH. Evolving Trends Towards Minimally Invasive Surgery for Solid-Pseudopapillary Neoplasms. Ann Surg Oncol. 2016 Dec;23(13):4165-4168. PubMed PMID: 27510845
• Meguid C, Schulick RD, Schefter TE, Lieu CH, Boniface M, Williams N, Vogel JD, Gajdos C, McCarter M, Edil BH. The Multidisciplinary Approach to GI Cancer Results in Change of Diagnosis and Management of Patients. Multidisciplinary Care Impacts Diagnosis and Management of Patients. Ann Surg Oncol. 2016 Nov;23(12):3986-3990. PubMed PMID: 27342825
• Boniface MM, Wani SB, Schefter TE, Koo PJ, Meguid C, Leong S, Kaplan JB, Wingrove LJ, McCarter MD. Multidisciplinary management for esophageal and gastric cancer. Cancer Manag Res. 2016 Apr 22;8:39-44. PubMed PMID: 27217796
• Chapman, B., McCulough, J., Overbey, D., Paniccia, A., Meguid, C., Gleisner, A., McCarter, M., Gajdos C., Schulick, RD., & Edil, BH. (2016). Empiric Post-Operative Metocloperamide Reduces Delayed Gastric Emptying After Pancreaticoduodenectomy. Gastroenterology.
• Chapman, B, Paniccia, A., McCullough, J., Overbey, D., Meguid, C., Gleisner, A., Gajdos, C., Schulick, RD., McCarter, M. & Edil, BH. (2016). Neoadjuvant FOLFIRINOX for Pancreatic Ductal Adenocarcinoma is Associated with Improved Clinicopathologic Outcomes and Equivalent Morbidity and Mortality Following Pancreaticoduodenectomy. Gastroenterology.
• Stewart CL, Meguid C, Chapman B, Schulick R, Edil BH. Evolving Trends Towards Minimally Invasive Surgery for Solid-Pseudopapillary Neoplasms. Ann Surg Oncol. 2016 Dec;23(13):4165-4168. PubMed PMID: 27510845
• Meguid C, Schulick RD, Schefter TE, Lieu CH, Boniface M, Williams N, Vogel JD, Gajdos C, McCarter M, Edil BH. The Multidisciplinary Approach to GI Cancer Results in Change of Diagnosis and Management of Patients. Multidisciplinary Care Impacts Diagnosis and Management of Patients. Ann Surg Oncol. 2016 Nov;23(12):3986-3990. PubMed PMID: 27342825
• Boniface MM, Wani SB, Schefter TE, Koo PJ, Meguid C, Leong S, Kaplan JB, Wingrove LJ, McCarter MD. Multidisciplinary management for esophageal and gastric cancer. Cancer Manag Res. 2016;8:39-44. PubMed PMID: 27217796
• Meguid C, Ryan CE, Edil BH, Schulick RD, Gajdos C, Boniface M, Schefter TE, Purcell WT, McCarter M. Establishing a framework for building multidisciplinary programs. J Multidiscip Healthc. 2015;8:519-26. PubMed PMID: 26664132
• Meguid C, Ryan CE, Edil BH, Schulick RD, Gajdos C, Boniface M, Schefter TE, Purcell WT, McCarter M. Establishing a framework for building multidisciplinary programs. J Multidiscip Healthc. 2015;8:519-26. PubMed PMID: 26664132
• Paniccia A, Edil BH, Schulick RD, Byers JT, Meguid C, Gajdos C, McCarter MD. Neoadjuvant FOLFIRINOX application in borderline resectable pancreatic adenocarcinoma: a retrospective cohort study. Medicine (Baltimore). 2014 Dec;93(27):e198. PubMed PMID: 25501072
• Paniccia A, Edil BH, Schulick RD, Byers JT, Meguid C, Gajdos C, McCarter MD. Neoadjuvant FOLFIRINOX application in borderline resectable pancreatic adenocarcinoma: a retrospective cohort study. Medicine (Baltimore). 2014 Dec;93(27):e198. PubMed PMID: 25501072
• Paniccia A, Edil BH, Schulick RD, Byers JT, Meguid C, Gajdos C, McCarter MD. Neoadjuvant FOLFIRINOX application in borderline resectable pancreatic adenocarcinoma: a retrospective cohort study. Medicine (Baltimore). 2014 Dec;93(27):e198. PubMed PMID: 25501072
• Chapman BC, Gleisner A, Ibrahim-Zada I, Overbey DM, Paniccia A, Meguid C, Brauer B, Gajdos C, McCarter MD, Schulick RD, Edil BH. Laparoscopic pancreaticoduodenectomy: changing the management of ampullary neoplasms. Surg Endosc. 2018 Feb;32(2):915-922. PubMed PMID: 28779245

Professional Memberships

• American Academy of Nurse Practitioners (AANP), Member
• American College of Nurse Practitioners (ACNP), Member

Practice Locations

• University of Colorado Hospital

• University of Colorado Cancer Center

Specialty Information

• Cancers - Pancreatic Cancer
• Cancers